California State Teachers Retirement System (CalSTRS)’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-47,243
Closed -$409K 3259
2022
Q1
$409K Buy
47,243
+5,735
+14% +$58.8K ﹤0.01% 2465
2021
Q4
$593K Buy
41,508
+25,129
+153% +$525K ﹤0.01% 2449
2021
Q3
$360K Sell
16,379
-20,541
-56% -$350K ﹤0.01% 2551
2021
Q2
$494K Buy
+36,920
New +$422K ﹤0.01% 2643

Other funds holding ORMP

California State Teachers Retirement System (CalSTRS)'s ORMP Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 47,243 shares — an estimated $409K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ORMP in Q2 2021 and held it in 4 quarters. The position peaked at $593K in Q4 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 47,243 Oramed Pharmaceuticals shares in Q2 2022, an estimated $409K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Oramed Pharmaceuticals position peaked at $593K in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.